Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Gruvaktiebolaget Viscaria | VISC | Jan 10, 2025 | 20.20 | 0.00 |
Gränges | GRNG | Jan 10, 2025 | 129.10 | -1.22 |
Grängesberg Exploration Holding | GRANGX | Jan 10, 2025 | 10.30 | -1.53 |
Guard Therapeutics International | GUARD | Jan 10, 2025 | 21.00 | -2.78 |
Guideline Geo | GGEO | Jan 10, 2025 | 8.66 | -2.48 |
Gullberg & Jansson | GJAB | Jan 10, 2025 | 14.75 | +7.27 |
H&D Wireless Sweden Holding B | HDWB | Jan 10, 2025 | 0.00 | 0.00 |
H&M B | HMB | Jan 10, 2025 | 144.55 | -1.16 |
HAKI Safety A | HAKIA | Jan 10, 2025 | 28.00 | -0.71 |
HAKI Safety B | HAKIB | Jan 10, 2025 | 25.00 | -0.79 |
Hamlet BioPharma AB (publ) | HAMLETB | Jan 10, 2025 | 3.33 | -0.60 |
Hansa Biopharma | HNSA | Jan 10, 2025 | 34.78 | -0.69 |
Hanza AB | HANZA | Jan 10, 2025 | 75.25 | -1.63 |
Harm Reduction Group | NOHARM | Jan 10, 2025 | 0.05 | +4.27 |
Havsfrun Investment | HAVS | Jan 10, 2025 | 13.45 | +1.13 |
Havsfrun Investment B | HAVB | Jan 10, 2025 | 13.45 | +1.13 |
Haypp Group | HAYPP | Jan 10, 2025 | 60.00 | -0.66 |
Headsent | VIMAB | Jan 10, 2025 | 10.70 | 0.00 |
Heba B | HEBAB | Jan 10, 2025 | 30.15 | -1.79 |
Hedera Group | HEGR | Jan 10, 2025 | 3.48 | +4.19 |
Heimstaden Pref | HEIMPREF | Jan 10, 2025 | 15.54 | +0.65 |
Heliospectra | HELIO | Jan 10, 2025 | 0.38 | -0.27 |
Hemnet Group | HEM | Jan 10, 2025 | 352.40 | +0.17 |
Hemply Balance | HMPLY | Jan 10, 2025 | 0.04 | 0.00 |
Hernö Gin B | HERNOB | Jan 10, 2025 | 3.90 | -0.13 |
Hexagon B | HEXAB | Jan 10, 2025 | 106.40 | -0.79 |
Hexagon Purus | HPURO | Jan 10, 2025 | 4.86 | -2.02 |
Hexatronic Group | HTRO | Jan 10, 2025 | 34.24 | -3.79 |
Hexicon | HEXI | Jan 10, 2025 | 0.18 | -3.47 |
Hexpol B | HPOLB | Jan 10, 2025 | 100.80 | -2.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.